Metis Neurotec

METIS at the 3rd Japanese-German-French AI Symposium in Tokyo

At the 3rd trilateral Japanese-French-German Symposium on Artificial Intelligence (AI) in Tokyo, experts from academia, industry, and policy-making gathered to discuss measures for tackling planetary challenges and realizing a sustainable society. Dr. Simon Stock from METIS spoke about AI in Health and the challenges of moving from research to industry. He explained the complexity of getting medical data and using AI for real-world medical applications. He spoke at the Session “AI for health”, which focused on how AI technology can be used to “ensure healthy lives and promote well-being for all at all ages,” as outlined in the Sustainable Development Goals (SDGs) set by the United Nations. Dr. Simon Stock also pitched METIS at the plenary session “AI shooting stars” together with other promising AI-enabled startups from all participating countries. METIS received positive feedback about their AI-enabled risk factor intervention for dementia patients. Especially Japan is an interesting market for METIS, as it has the eldest population worldwide. Also, dementia is on the rise in Japan. We can already today learn a lot about aging from Japan’s society. Also, France faces the same challenges from demographic change. Hence, the goal of Metis is to further pursue international collaborations with those countries in order to learn about dementia and possible interventions.

Image source: Copyright: DWIH Tokyo / Shimazu
Image source: Copyright: DWIH Tokyo / Shimazu

300 participants were on site in Tokyo, while 400 joined the live stream online. The symposium was a great success in raising awareness about AI and its potential to improve our lives.

METIS Neurotec

Zusammen gegen neurologische Krankheiten.

METIS wurde 2021 durch eine Förderung der Hemholtz-Gemeinschaft ins Leben gerufen. Das in Karlsruhe angesiedelte METIS hat das Ziel, Deep Tech auf den Bereich der Demenzbehandlung und der digitalen Gesundheitsversorgung zu transferieren.

METIS Neurotec

Together against neurological diseases.

METIS was called into existence by funding from the Hemholtz Association in 2021.
Located in Karlsruhe, Germany, METIS aims to transfer deep tech to the field of dementia treatment und digital healthcare.

Aktuelle Artikel
Ähnliche Artikel

METIS in Frankfurt

On 22.03.2023, the networking meeting of the BMBF funding measures “Gründungen: Innovative Start-ups for Human-Technology Interaction” (START MTI) and “START-interactive: Interactive Technologies for Health and Quality of Life” (START-i) took place. With START, the BMBF aims to strengthen the innovation


Interview with NEULAND

We were interviewed by the KIT magazine “NEULAND” about our startup Metis Neurotec. In the magazine you can now read what makes our startup so special and which approaches we envision in our treatment concept against dementia. The symptoms of


Leave a Reply

Your email address will not be published. Required fields are marked *

WordPress Cookie Notice by Real Cookie Banner